TransEnterix, Inc. To Present At The Stifel 2016 Healthcare Conference

TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2016 Healthcare Conference at the Lotte New York Palace Hotel in New York. The presentation is scheduled to take place at 8:45 am Eastern Time on Tuesday, November 15, 2016.

About TransEnterix

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform. The Senhance Surgical Robotic System has been granted a CE Mark but is not currently available for sale in the United States. For more information, visit the TransEnterix website at www.transenterix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161108005738/en/
Copyright Business Wire 2010

If you liked this article you might like

7 Stocks Under $10 That Could Make You a Lot of Money

7 Stocks Under $10 Making Big Moves Higher

TransEnterix (TRXC) Stock Tumbles After Posting Q1 Results

7 Stocks Under $10 Spiking Toward Big Gains

7 Stocks Under $10 to Trade for Big Profits